This was confirmed by a recent study showing a direct correlation between high serum LDH activity and high TNM staging in breast cancer patients (Agrawal et al., 2016), including those with a triple negative hormone receptor status (Chen et al., 2016). The gene discussed is NR4A1; the disease is breast cancer.